New Class of Drugs Promising for BRCA-Related Cancers
9th July 2009 by admin 1 CommentNew drugs called PARP inhibitors appear to have a lot of promise against hereditary cancers caused by BRCA1 and BRCA2 cell mutations.
PARP inhibitors work by blocking the action of poly (ADP-ribose) polymerase, an enzyme that helps repair DNA. In certain tumor cells, such as those from BRCA1 and BRCA2 mutation carriers, blocking this enzyme can [...]